Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heike Wulff

Showing results (71-80 of 222) with videos related to

Pageof 23
Sort By:
Molecular Pharmacology|January 28, 2017
Structural Insights into the Atomistic Mechanisms of Action of Small Molecule Inhibitors Targeting the KCa3.1 Channel PoreHai M Nguyen, Vikrant Singh, Brandon Pressly, et al.
Frontiers in Pharmacology|June 26, 2024
Toward high-resolution modeling of small molecule-ion channel interactionsBrandon J Harris, Phuong T Nguyen, Guangfeng Zhou, et al.
Molecular Pharmacology|July 6, 2010
Potassium channel block by a tripartite complex of two cationophilic ligands and a potassium ionPavel I Zimin, Bojan Garic, Silke B Bodendiek, et al.
Molecular Pharmacology|February 1, 2014
Nanomolar bifenthrin alters synchronous Ca2+ oscillations and cortical neuron development independent of sodium channel activityZhengyu Cao, Yanjun Cui, Hai M Nguyen, et al.
BMJ Open Diabetes Research & Care|December 15, 2020
Acute and chronic neuroinflammation is triggered by diabetic ketoacidosis in a rat modelNicole Glaser, Steven Chu, Benjamin Hung, et al.
Scientific Reports|December 8, 2017
Structural insights into the potency of SK channel positive modulatorsYoung-Woo Nam, Razan Orfali, Tingting Liu, et al.
Pharmacological Reviews|December 31, 2005
International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channelsAguan D Wei, George A Gutman, Richard Aldrich, et al.
Molecular Pharmacology|August 16, 2005
Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseasesAlexander Schmitz, Ananthakrishnan Sankaranarayanan, Philippe Azam, et al.
Toxicology and Applied Pharmacology|July 15, 2021
The efficacy of γ-aminobutyric acid type A receptor (GABA <sub>A</sub>R) subtype-selective positive allosteric modulators in blocking tetramethylenedisulfotetramine (TETS)-induced seizure-like behavior in larval zebrafish with minimal sedationPaige C Mundy, Brandon Pressly, Dennis R Carty, et al.
Frontiers in Physiology|January 2, 2023
Editorial: Ion channels in health and diseaseAhmed Al-Sabi, Tarek Mohamed Abd El-Aziz, Peilin Yu, et al.
Pageof 23

Showing results (71-80 of 222) with videos related to

Sort By:
Pageof 23
Molecular Pharmacology|January 28, 2017
Structural Insights into the Atomistic Mechanisms of Action of Small Molecule Inhibitors Targeting the KCa3.1 Channel PoreHai M Nguyen, Vikrant Singh, Brandon Pressly, et al.
Frontiers in Pharmacology|June 26, 2024
Toward high-resolution modeling of small molecule-ion channel interactionsBrandon J Harris, Phuong T Nguyen, Guangfeng Zhou, et al.
Molecular Pharmacology|July 6, 2010
Potassium channel block by a tripartite complex of two cationophilic ligands and a potassium ionPavel I Zimin, Bojan Garic, Silke B Bodendiek, et al.
Molecular Pharmacology|February 1, 2014
Nanomolar bifenthrin alters synchronous Ca2+ oscillations and cortical neuron development independent of sodium channel activityZhengyu Cao, Yanjun Cui, Hai M Nguyen, et al.
BMJ Open Diabetes Research & Care|December 15, 2020
Acute and chronic neuroinflammation is triggered by diabetic ketoacidosis in a rat modelNicole Glaser, Steven Chu, Benjamin Hung, et al.
Scientific Reports|December 8, 2017
Structural insights into the potency of SK channel positive modulatorsYoung-Woo Nam, Razan Orfali, Tingting Liu, et al.
Pharmacological Reviews|December 31, 2005
International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channelsAguan D Wei, George A Gutman, Richard Aldrich, et al.
Molecular Pharmacology|August 16, 2005
Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseasesAlexander Schmitz, Ananthakrishnan Sankaranarayanan, Philippe Azam, et al.
Toxicology and Applied Pharmacology|July 15, 2021
The efficacy of γ-aminobutyric acid type A receptor (GABA <sub>A</sub>R) subtype-selective positive allosteric modulators in blocking tetramethylenedisulfotetramine (TETS)-induced seizure-like behavior in larval zebrafish with minimal sedationPaige C Mundy, Brandon Pressly, Dennis R Carty, et al.
Frontiers in Physiology|January 2, 2023
Editorial: Ion channels in health and diseaseAhmed Al-Sabi, Tarek Mohamed Abd El-Aziz, Peilin Yu, et al.
Pageof 23